NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia to Present FLEX Study Data on Impact of BluePrint at ESMO Breast Cancer 2025
Real-world analysis shows BluePrintยฎ identifies chemotherapy-sensitive Basal-type tumorsย among MammaPrintยฎ High Risk HR+ HER2- breast cancers, supporting more personalizedย treatment strategies.ย IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ May 6, 2025 โ Agendiaยฎ, Inc., Read More
Agendia Spotlights New Data on Genomic Testing at 26th American Society of Breast Surgeons Annual Meeting
Poster presentation to highlight new data on MammaPrintยฎ and BluePrintยฎ utility for informing axillary surgery decisions in the neoadjuvant setting. Agendia to present at Breast Fellows University Annual Meeting and host Educational Dinner Symposium Read More
MammaPrintยฎ Reimbursement Indication Extended in Belgium
IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ February 11, 2025 โ Agendiaยฎ, Inc. announced today that the National Institute for Sickness and Invalidity Insurance (INAMI-RIZIV) located in Brussels has expanded the reimbursement indication for Read More
Newsroom
News, Stories & Breast Cancer Blog
Anthracyclines and Treatment of Early-Stage Breast Cancer
For decades, anthracyclines have played an important role in treating early-stage breast cancer. But whether this class of drugs should continue to be recommended in early disease given that other available therapies are less Read More
Improving Tailored Treatment Plans in HR+ and HER2- Early Breast Cancer
Genomic profiling in the FLEX trial predicted chemotherapy response in HR+, HER2- breast cancer, which could enable tailored treatment plans. Inย an abstractย presented at theย 2024 San Antonio Breast Cancer Symposium, researchers used genomic profiling in Read More
Healthcare Tech Outlook Named Agendia as One of the Top 10 Precision Oncology Solutions Providers in 2024
We are happy to announce Agendia has been named one of the Top 10 Precision Oncology Solutions Providers in 2024. Agendia is proud to be a part of the precision medicine movement with our Read More
What Is Neoadjuvant Chemotherapy?
If you or a loved one has been diagnosed with cancer, your care team may recommend chemotherapy, one of the most common types of cancer treatment available. Chemotherapy involves the use of medications that Read More
What Can We Learn From A Highly Diverse Observational Study Of 17,000+ Breast Cancer Patients?
A conversation with Agendia CMO William Audeh, MD More than 17,000 patients have enrolled in Agendiaโs FLEX trial studying full genome profiling and complete clinical data for those diagnosed with stages I, II, or Read More
How Agendia is personalizing breast cancer treatment
By Abbey Bowling | October 29, 2024 October is Breast Cancer Awareness Month, andย Agendia, one of the leading providers in the field of precision oncology is working to make a significant impact in Read More
How a Pregnant Woman Diagnosed With Breast Cancer Was Helped by MammaPrint
Aleseia Saunders was 32 when she felt a lump in her right breast. Being so young with no family history of breast cancer, she shrugged it off as being a cyst and went on Read More
